Thomas Steyer’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Thomas Steyer’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,225,000	Closed	-$167M	–	161
2020 Q3	$167M	Buy	1,225,000 +350,000	+40%	+$37.2M	1.16%	34
2020 Q2	$84.5M	Buy	875,000 +445,000	+103%	+$37.1M	0.68%	42
2020 Q1	$20.2M	Sell	430,000 -1,620,000	-79%	-$104M	0.17%	68
2019 Q4	$149M	Buy	2,050,000 +19,603	+1%	+$1.19M	1.01%	32
2019 Q3	$106M	Buy	2,030,397 +30,397	+2%	+$1.62M	0.8%	32
2019 Q2	$100M	Buy	2,000,000 +49,722	+3%	+$2.42M	0.65%	34
2019 Q1	$101M	Buy	1,950,278 +350,000	+22%	+$16.1M	0.76%	36
2018 Q4	$78.2M	Buy	1,600,278 +69,000	+5%	+$3.8M	0.57%	38
2018 Q3	$99.8M	Buy	1,531,278 +50,000	+3%	+$2.94M	0.59%	35
2018 Q2	$73.5M	Buy	1,481,278 +442,000	+43%	+$21.4M	0.45%	42
2018 Q1	$50.7M	Buy	1,039,278 +175,546	+20%	+$9.13M	0.35%	50
2017 Q4	$36.4M	Buy	863,732 +466,232	+117%	+$18M	0.3%	45
2017 Q3	$17M	Buy	+397,500	New	+$12.7M	0.15%	60

Thomas Steyer's MYOK Position: Q4 2020 in Review

Thomas Steyer sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,225,000 shares — an estimated $167M sold.

Thomas Steyer first reported a position in MYOK in Q3 2017 and held it in 13 quarters. The position peaked at $167M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Thomas Steyer reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Thomas Steyer sold 1,225,000 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $167M.
Thomas Steyer first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
Thomas Steyer's MyoKardia, Inc. Common Stock position peaked at $167M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Farallon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.